Detalhe da pesquisa
1.
Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.
Proc Natl Acad Sci U S A
; 113(26): E3609-18, 2016 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27274048
2.
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut-Point Suitability Across Tumor Types.
J Clin Pharmacol
; 64(1): 125-136, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656820
3.
Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies.
Cell Chem Biol
; 23(6): 655-65, 2016 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27341433